170 related articles for article (PubMed ID: 32606728)
1. Diosgenin and GSK126 Produce Synergistic Effects on Epithelial-Mesenchymal Transition in Gastric Cancer Cells by Mediating EZH2 via the Rho/ROCK Signaling Pathway.
Liu S; Rong G; Li X; Geng L; Zeng Z; Jiang D; Yang J; Wei Y
Onco Targets Ther; 2020; 13():5057-5067. PubMed ID: 32606728
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of EZH2 and EGFR produces a synergistic effect on cell apoptosis by increasing autophagy in gastric cancer cells.
Yang Y; Zhu F; Wang Q; Ding Y; Ying R; Zeng L
Onco Targets Ther; 2018; 11():8455-8463. PubMed ID: 30555238
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of EZH2 and activation of ERRγ synergistically suppresses gastric cancer by inhibiting FOXM1 signaling pathway.
Huang B; Mu P; Yu Y; Zhu W; Jiang T; Deng R; Feng G; Wen J; Zhu X; Deng Y
Gastric Cancer; 2021 Jan; 24(1):72-84. PubMed ID: 32529327
[TBL] [Abstract][Full Text] [Related]
4. [Effect of a novel EZH2 inhibitor GSK126 on prostate cancer cells].
Lin W; Chen Y; Zeng L; Ying R; Zhu F
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2016 May; 45(4):356-363. PubMed ID: 27868408
[TBL] [Abstract][Full Text] [Related]
5. Diosgenin exhibits tumor suppressive function via down-regulation of EZH2 in pancreatic cancer cells.
Guo W; Chen Y; Gao J; Zhong K; Wei H; Li K; Tang M; Zhao X; Liu X; Nie C; Yuan Z
Cell Cycle; 2019 Aug; 18(15):1745-1758. PubMed ID: 31213123
[TBL] [Abstract][Full Text] [Related]
6. Blocking EZH2 methylation transferase activity by GSK126 decreases stem cell-like myeloma cells.
Zeng D; Liu M; Pan J
Oncotarget; 2017 Jan; 8(2):3396-3411. PubMed ID: 27926488
[TBL] [Abstract][Full Text] [Related]
7. Targeting the EZH2-PPAR Axis Is a Potential Therapeutic Pathway for Pancreatic Cancer.
Hu J; Zheng Z; Lei J; Cao Y; Li Q; Zheng Z; Chen C
PPAR Res; 2021; 2021():5589342. PubMed ID: 34335707
[TBL] [Abstract][Full Text] [Related]
8. MiRNA-26a Contributes to the Acquisition of Malignant Behaviors of Doctaxel-Resistant Lung Adenocarcinoma Cells through Targeting EZH2.
Chen J; Xu Y; Tao L; Pan Y; Zhang K; Wang R; Chen LB; Chu X
Cell Physiol Biochem; 2017; 41(2):583-597. PubMed ID: 28214878
[TBL] [Abstract][Full Text] [Related]
9. LncRNA HOXA-AS2 Promotes Oral Squamous Cell Proliferation, Migration, and Invasion via Upregulating EZH2 as an Oncogene.
Zhao Z; Xing Y; Yang F; Zhao Z; Shen Y; Song J; Jing S
Technol Cancer Res Treat; 2021; 20():15330338211039109. PubMed ID: 34519570
[TBL] [Abstract][Full Text] [Related]
10. Dysregulated lipid metabolism blunts the sensitivity of cancer cells to EZH2 inhibitor.
Zhang T; Guo Z; Huo X; Gong Y; Li C; Huang J; Wang Y; Feng H; Ma X; Jiang C; Yin Q; Xue L
EBioMedicine; 2022 Mar; 77():103872. PubMed ID: 35158113
[TBL] [Abstract][Full Text] [Related]
11. EZH2 inhibition promotes epithelial-to-mesenchymal transition in ovarian cancer cells.
Cardenas H; Zhao J; Vieth E; Nephew KP; Matei D
Oncotarget; 2016 Dec; 7(51):84453-84467. PubMed ID: 27563817
[TBL] [Abstract][Full Text] [Related]
12. The novel EZH2 inhibitor, GSK126, suppresses cell migration and angiogenesis via down-regulating VEGF-A.
Chen YT; Zhu F; Lin WR; Ying RB; Yang YP; Zeng LH
Cancer Chemother Pharmacol; 2016 Apr; 77(4):757-65. PubMed ID: 26898301
[TBL] [Abstract][Full Text] [Related]
13. MiRNA-506 presents multiple tumor suppressor activities by targeting EZH2 in nasopharyngeal carcinoma.
Fan DC; Zhao YR; Qi H; Hou JX; Zhang TH
Auris Nasus Larynx; 2020 Aug; 47(4):632-642. PubMed ID: 31932074
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of EZH2 via activation of SAPK/JNK and reduction of p65 and DNMT1 as a novel mechanism in inhibition of human lung cancer cells by polyphyllin I.
Li L; Wu J; Zheng F; Tang Q; Wu W; Hann SS
J Exp Clin Cancer Res; 2016 Jul; 35(1):112. PubMed ID: 27421653
[TBL] [Abstract][Full Text] [Related]
15. Diosgenin inhibits the proliferation, migration and invasion of the optic nerve sheath meningioma cells via induction of mitochondrial-mediated apoptosis, autophagy and G0/G1 cell cycle arrest.
Zhu X; Chen Z; Li X
J BUON; 2020; 25(1):508-513. PubMed ID: 32277676
[TBL] [Abstract][Full Text] [Related]
16. Diosgenin inhibits the expression of NEDD4 in prostate cancer cells.
Zhang J; Xie JJ; Zhou SJ; Chen J; Hu Q; Pu JX; Lu JL
Am J Transl Res; 2019; 11(6):3461-3471. PubMed ID: 31312358
[TBL] [Abstract][Full Text] [Related]
17. GSK126 an inhibitor of epigenetic regulator EZH2 suppresses cardiac fibrosis by regulating the
Aziz S; Yalan L; Raza MA; Lemin J; Akram HMB; Zhao W
Biochem Cell Biol; 2023 Feb; 101(1):87-100. PubMed ID: 36469862
[TBL] [Abstract][Full Text] [Related]
18. Dextran Sulfate Inhibits Cell Proliferation and Induces Apoptosis by Regulating EZH2 in Gastric Carcinoma.
Huang Y; Wang W; Xu YY; Guo J; Jiao L; Wang H; Li M; Yang Q
Curr Cancer Drug Targets; 2021; 21(11):953-964. PubMed ID: 34551698
[TBL] [Abstract][Full Text] [Related]
19. PTEN Is Fundamental for Elimination of Leukemia Stem Cells Mediated by GSK126 Targeting EZH2 in Chronic Myelogenous Leukemia.
Zhou J; Nie D; Li J; Du X; Lu Y; Li Y; Liu C; Dai W; Wang Y; Jin Y; Pan J
Clin Cancer Res; 2018 Jan; 24(1):145-157. PubMed ID: 29070525
[No Abstract] [Full Text] [Related]
20. EZH2 Inhibitor GSK126 Suppresses Antitumor Immunity by Driving Production of Myeloid-Derived Suppressor Cells.
Huang S; Wang Z; Zhou J; Huang J; Zhou L; Luo J; Wan YY; Long H; Zhu B
Cancer Res; 2019 Apr; 79(8):2009-2020. PubMed ID: 30737232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
